IL17A and neurodevelopmental disorder: Our findings suggest that targeting the embryonic IL-17A pathway during pregnancy may prevent some forms of neurodevelopmental disorders, such as abnormalities in vocalization, anxiety-like and repetitive behavior, which are hallmarks of autism spectrum disorders.